News
As the popularity of medications for weight loss, such as Ozempic and Wegovy, surges across North America, new research ...
Bodybuilding legend and former seven-time Mr. Olympia Arnold Schwarzenegger discussed if using GLP-1 drugs destroy lean ...
The expert has revealed why the GLP-1 medication could be playing a role in the bedroom and paving the way for divorce in ...
DoseSpot, which delivers best-in-class e-prescribing, insurance verification and revenue cycle management solutions for healthcare providers, announced today the results of a new data analysis on 102, ...
A new study reveals that weight lost with GLP-1 drugs, such as semaglutide, is regained within a year after stopping ...
Eli Lilly’s Zepbound transformed weight loss drug market since debut 18 months ago 4.5 million people reportedly taking Lilly ...
Viking Therapeutics's obesity/diabetes candidates and strong financials position it for success. Read here for an investment ...
Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...
GLP-1RAs were associated with improved quality of life and emotional eating behaviors among individuals with overweight and obesity.
The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.
So far, benefits associated with consistent GLP-1 use in curbing medical spending lack sufficient data-backed evidence. It’s ...
Eli Lilly (LLY 1.15%) and Novo Nordisk (NVO 0.14%) are two phenomenal growth stocks that investors probably can't go wrong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results